(Q50874092)

24 March 2018

title

Tamoxifen inhibits macrophage FABP4 expression through the combined effects of the GR and PPARγ pathways. (English)

1 reference

24 March 2018

1 reference

Meixiu Jiang

1

1 reference

24 March 2018

Ling Zhang

2

1 reference

24 March 2018

Xingzhe Ma

3

1 reference

24 March 2018

Wenquan Hu

4

1 reference

24 March 2018

Yuanli Chen

5

1 reference

24 March 2018

Miao Yu

6

1 reference

24 March 2018

Qixue Wang

7

1 reference

24 March 2018

Xiaoju Li

8

1 reference

24 March 2018

Zhinan Yin

9

1 reference

24 March 2018

Yan Zhu

10

1 reference

24 March 2018

Xiumei Gao

11

1 reference

24 March 2018

David P Hajjar

12

1 reference

24 March 2018

Yajun Duan

13

1 reference

24 March 2018

Jihong Han

14

1 reference

24 March 2018

language of work or name

English

0 references

publication date

1 September 2013

1 reference

24 March 2018

published in

Biochemical Journal

1 reference

24 March 2018

volume

454

1 reference

24 March 2018

issue

3

1 reference

24 March 2018

page(s)

467-477

1 reference

24 March 2018

Fatty acid-binding proteins--insights from genetic manipulations

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Improved glucose and lipid metabolism in genetically obese mice lacking aP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Peroxisome proliferator activated receptor gamma, CCAAT/enhancer-binding protein alpha, and cell cycle status regulate the commitment to adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Statins synergize dexamethasone-induced adipocyte fatty acid binding protein expression in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Molecular therapy of breast cancer: progress and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Study of the mechanisms involved in the vasorelaxation induced by (-)-epigallocatechin-3-gallate in rat aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Tamoxifen improves endothelial function and reduces carotid intima-media thickness in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Influence of tamoxifen on carotid intima-media thickness in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Tamoxifen effects on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Regulation of lipid droplet cholesterol efflux from macrophage foam cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Deficiency of PXR decreases atherosclerosis in apoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Adipogenic differentiating agents regulate expression of fatty acid binding protein and CD36 in the J744 macrophage cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Activation of liver X receptor induces macrophage interleukin-5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Estrogen signaling and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

A woman's heart: the impact of adjuvant endocrine therapy on cardiovascular health

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Clinical review: Effect of endocrine therapies on bone in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Synergistic upregulation of low-density lipoprotein receptor activity by tamoxifen and lovastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Long term effects of tamoxifen on blood lipid values in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Induction of macrophage scavenger receptor type BI expression by tamoxifen and 4-hydroxytamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Expression of the differentiation-induced gene for fatty acid-binding protein is activated by glucocorticoid and cAMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

Circulating Adipocyte Fatty Acid-Binding Protein Levels and Cardiovascular Morbidity and Mortality in Patients With Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20130580

21 January 2018

Identifiers

DOI

10.1042/BJ20130580

1 reference

24 March 2018

PubMed ID

23805908

1 reference

24 March 2018